drugset / Trial / NCT06579287
A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to explore the safety and efficacy of SHJ002 Sterile Ophthalmic Solution relative to atropine in myopia control SHJ002 is an antisense oligonucleotide to neutralize a specific microRNA.
Timeline
- Start
- 2025-01-22
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atropine | Other / unclassified | — | Topical |
| Subject | SHJ002 | Antisense oligonucleotide | — | Topical |